Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
Matthew D. Resch(TechnoVax (United States)), Jose M. Galarza(TechnoVax (United States))
Cited by 10
Related Papers
Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications
|Frontiers in Medical Technology|2023|3